Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Williamsport, PA MSA — September 2026
Williamsport's thin life sci bench meets Philadelphia's hiring pull.
Williamsport's 3.8% unemployment and manufacturing growth of 2.7% mask a scientific-talent gap as Philadelphia employers recruit 100+ combined life sciences roles this month.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Williamsport MSA unemployment: 3.8% — Down from 4.5% in March 2026
- PA life sciences job postings: 3x YoY — August 2026, statewide
- PA average weekly wage: -0.8% YoY — $1,149/week, June 2026
- Williamsport manufacturing employment growth: 2.7% YoY — 7.7K jobs, July 2026
Key takeaways
Regional talent thinness amplifies Philadelphia's pull.
GSK and Insmed are recruiting 100+ combined roles in Greater Philadelphia this month, a magnet effect that a labor force of roughly 53,000 in Williamsport cannot counterbalance. Retention risk concentrates in regulatory, quality, and manufacturing science roles where candidates have genuine alternatives two hours south.
Manufacturing strength masks a scientific-talent gap.
Williamsport's 2.7% year-over-year manufacturing job growth reflects general industrial activity, not necessarily life sciences-specific hiring capacity. Leaders should not read local manufacturing momentum as evidence the metro can staff cell/gene or complex bioprocess roles without outside recruitment or CDMO support.
Statewide wage stagnation may suppress urgency to counteroffer.
Pennsylvania's average weekly wage fell 0.8% year-over-year even as job postings tripled, consistent with employers testing whether candidates will accept flat offers amid reduced quit rates. Current conditions suggest organizations should evaluate whether this is a short-lived opportunity to secure scarce regulatory or CMC talent before postings convert to accepted offers elsewhere.
CDMO partnerships look increasingly rational for smaller Williamsport-area biotech.
Minaris' AAV optimization partnership with Asimov and continued Philadelphia CDMO capacity expansion signal that outsourcing specialized production no longer means sacrificing technical sophistication. For a metro with limited bench strength in cell and gene therapy skillsets, this tips build-vs-outsource math further toward partnership.
Median advertised pay by role — Williamsport, PA MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $89,211 | $124,624 | $141,205 | Significant increase | $131,354 |
| Clinical Research Associate * | $61,167 | $80,883 | $100,914 | Significant increase | $90,956 |
| Lab Technician * | $39,619 | $46,681 | $52,287 | Moderate decline | $47,402 |
| Regulatory Affairs Specialist * | $66,798 | $95,346 | $112,818 | Stable | $104,000 |
| Clinical Data Manager * | $97,693 | $142,800 | $164,232 | Moderate increase | $123,031 |
| Biostatistician * | $107,580 | $139,109 | $159,860 | Moderate increase | $133,322 |
| Validation Engineer * | $89,151 | $106,202 | $113,415 | Stable | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Williamsport MSA unemployment held near 3.8% in the most recent reading, with manufacturing employment up 2.7% year-over-year, suggesting a tight regional labor pool well before Lycoming Engines or other specialized employers compete for scientific or technical talent. Statewide, Pennsylvania job postings tripled year-over-year in life sciences even as average unemployment near 4.2% has quietly eroded worker leverage on wages — a combination that leaves rural MSAs like Williamsport exposed to talent pull from Philadelphia's much deeper life sciences labor pool.
What it means
Williamsport's thin specialized talent base means any regulatory, quality, or manufacturing science opening competes directly against Philadelphia employers like GSK and Insmed who are actively recruiting 40-60+ roles each — a market this small cannot absorb that pull without losing candidates to relocation or remote-eligible postings. Build-vs-outsource calculus shifts further toward CDMO partnerships for specialized production (cell/gene, complex biologics) given how few locally available candidates can fill Director CMC or senior regulatory roles commanding $220K-$580K nationally. Consider reviewing whether critical R&D, quality, or regulatory vacancies in this metro are realistically fillable locally within target timelines, or whether partnering with a regional CDMO reduces both cost and time-to-capability.
Looking ahead
Worth watching: October 27 release of September Williamsport MSA employment data will confirm whether the 3.8% unemployment rate held or tightened further, directly affecting how aggressively local employers need to price offers for scarce technical roles.
Emerging pressure point: Continued large-scale recruiting out of Greater Philadelphia life sciences employers may accelerate outmigration of Williamsport-area regulatory and quality talent; watch local job board activity for signs candidates are fielding remote or relocation-based offers.
Potential inflection point: Pennsylvania's tripling of life sciences postings against flat statewide wage growth is an unstable combination — a reversal in either direction (wage acceleration or posting pullback) would reshape how Williamsport employers should benchmark against the Philadelphia market.
Early indicator: National biopharma layoffs (BioMarin, Bristol Myers) combined with 64% of firms still actively recruiting suggests displaced specialized talent may surface in regional candidate pools; monitor whether any of that talent reaches rural Pennsylvania postings or stays concentrated near major hubs.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.